This weeks people in the news post includes updates from the AHIMA on the appointment of Meryl Bloomrosen as vice president, Though Leadership, Practice Excellence and Public Policy. Additionally, two companies, Exalenz Bioscience and Avantas, have named new Sales executives. Finally, comes news from Welch Allyn that Vincent Caponi has joined their Board of Directors.
AHIMA Appoints Meryl Bloomrosen as Vice President of Thought Leadership, Practice Excellence and Public Policy
The American Health Information Management Association (AHIMA), the organization representing more than 67,000 Health Information Management professionals (HIM), has appointed Meryl Bloomrosen, MBA, RHIA, FAHIMA, as vice president, Thought Leadership, Practice Excellence and Public Policy.
“The knowledge and experience Meryl brings from her work in program management, public policy and government relations will benefit AHIMA as we continue to support our members, the HIM industry and the health care system during this transformative time,” said AHIMA CEO Lynne Thomas Gordon, MBA, RHIA, CAE, FACHE, FAHIMA. “HIM professionals are at the forefront of critical health information initiatives, and AHIMA remains committed to building quality healthcare through quality information. With her extensive and broad background, Meryl will be an asset to AHIMA as we continue to lead the profession and the industry.”
With more than 30 years of experience in health information, Bloomrosen joins AHIMA from the American Medical Informatics Association (AMIA), where she served as vice president, public policy and government relations. Prior to her work at AMIA, Bloomrosen served as the program manager of the Connecting Communities for Better Health Program at the eHealth Initiative (eHI). She also was a senior policy analyst at the Prospective Payment Assessment Commission (now MEDPAC).
An AHIMA member since 1977, Bloomrosen received her Master of Business Administration in information systems from George Washington University, a graduate certificate in Biomedical Informatics from Oregon Health Sciences University and a graduate certificate in health records administration from the U.S. Public Health Service. She also has completed the Medical Informatics MBL/NLM Course Fellowship program at the Marine Biological Laboratory in Woods Hole, Mass.
Exalenz Bioscience Appoints Gavin Doree New VP of Sales to Lead Company’s New Direct Sales Organization in the U.S.
Exalenz Bioscience, developer of advanced diagnostic systems that use a patient’s breath to detect and help manage gastrointestinal and liver conditions, today named Gavin Doree the company’s new vice president of sales.
Today’s news follows the world market launch of the BreathID(®) Hp, a second generation device, that using the real-time, continuous breath of a patient, detects the presence of the H. pylori bacteria, the cause of various illnesses including peptic ulcers and is associated with gastric cancer. It also follows Exalenz’s establishment of a new direct sales organization, which Doree has been hand-selected to lead in providing superior customer service and support.
“We are very excited that Gavin has joined the Exalenz family. He has a strong, successful history in the GI field as well as a great and impressive track record in various leadership roles. We are certain he is the right person to lead the new direct sales organization established in the U.S. and its part in the continued roll-out of the new BreathID Hp,” said Exalenz CEO Lawrence Cohen.
For the past two years, Mr. Doree has served as the national director and the director of strategic accounts at Medivators Inc. (formerly Minntech Corporation), a leader in developing, manufacturing, and marketing medical devices, specializing in patient safety, infection prevention and asset management technologies. As the national director of sales for Medivators in 2012-13, Mr. Doree managed sales of $35M US and was part of a leadership responsible for $157M US sales. He is also the former West Region director of sales at Byrne Medical, Inc., where, in 2009 he grew business by 36% for a total sales figure of more than $7 million. He repeated this success in 2010, when he further grew business by 23% for a total sales figure of more than $13 million. Mr. Doree also had strong success as territory manager at Parks Medical Corporation, where he helped the company to increase sales to the millions. Before pursuing a career in the medical field, Mr. Doree worked as an educator and athletic director in the State of Washington.
“This is an exciting time in the evolution of Exalenz. The company listened to its customers and developed a new generation system and a new market strategy that we expect will fill a large unmet market need. It took three years to develop the BreathID Hp, which unlike the original product, is EMR compatible and small enough to fit on a desk or countertop. Like the original, it too detects the H. pylori bacteria in the quickest, most highly accurate test on the market today. It’s the best of all worlds,” said Mr. Doree. “In terms of strategy, I’m keen to lead the new and highly professional direct sales team and to provide our clients with the very best customized, readily available, top quality service.”
Mr. Doree is the recipient of various awards including the Byrne Medical, Inc. Regional Director of the Year, three years running (2009-2011) and Sales Representative of the Year at Parks Medical in 2007 and 2008. He holds a BA in political science from the University of Washington and a masters in teaching from Whitworth University.
Ron Rheinheimer Joins Leading Healthcare Labor Management Company as Vice President; Will Lead Growth, Marketing and Drive New Business Initiatives
Avantas, a leading provider of strategic labor management technology, services, and strategies for the healthcare industry, today announced that Ron Rheinheimer has joined the company’s executive team as Vice President. Avantas recruited Rheinheimer in response to the company’s recent growth and continued market demand for its technology and services. As Vice President of Avantas, Rheinheimer will lead Avantas’ growth efforts focusing on business development and marketing initiatives, along with serving as a member of the senior executive team.
Over the last year, Avantas increased its workforce by 30 percent to meet the growing demand for its consulting services and labor management software. As the company continues to grow, Rheinheimer’s in-depth experience in growth strategies, innovation, and marketing a wide variety of emerging technologies will help lead Avantas’ expansion efforts.
“With increasing consolidation in the healthcare industry, we’ve seen a growing need for our enterprise labor management approach, as it enables an efficient, consistent labor management strategy for organizations to coordinate care across multiple locations,” said Chris Fox, CEO, Avantas. “Ron’s experience in managing and growing next-generation technology will be invaluable to our company as we continue to expand, and will help us ensure we continue to meet and exceed all of our clients’ needs.”
Since labor comprises the largest portion of a hospital or health system’s operating budget, optimization of staff can drive savings and improvements to quality across the entire organization. Avantas’ HELMTM methodology (healthcare enterprise labor management) represents a disruptive innovation for the healthcare industry, combining the science of workforce planning, demand forecasting, and operational best practices with a complete set of scheduling and staffing tools. This comprehensive approach challenges organizations to rethink what is possible with regard to labor management in all departments.
“Avantas enables healthcare organizations to address labor inefficiencies and realize sustainable, long-term gains,” said Ron Rheinheimer, Vice President, Avantas. “This is an exciting time to join a healthcare company like Avantas as the industry is going through a significant transformation with new regulations and the push to reduce inefficiencies. I’m thrilled to leverage my expertise in growing emerging technologies to help take our company to the next level and help our clients respond to this changing industry environment.”
Avantas’ SaaS-based solution, Smart Square®, is the only healthcare scheduling and productivity software that combines demand forecasting with robust scheduling functionality, enterprise transparency, and business intelligence tools all in one application. The flexible platform can interface with third-party IT systems, including a client’s existing HRIS, EMR, Time & Attendance, and Payroll systems, providing users timely access to actionable data they can leverage to drive significant improvements to clinical, operational, and financial outcomes.
Prior to joining Avantas, Rheinheimer served as Vice President of Strategy & Innovation in the K-12 Technology Group of Pearson. In this role he focused on next-generation learning platforms, the evolution of intelligent content, and learner engagement. Prior to this role, Rheinheimer was VP and GM of K-12 Integrated Learning Solutions (a joint effort between eCollege and Pearson School Systems) and Chief Marketing Officer in the School Systems group of Pearson. Before this, Rheinheimer held a number of executive-level positions at early-stage companies focusing of emerging technology solutions.
Vincent Caponi Joins Welch Allyn Board of Directors
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, today announced that Vincent C. Caponi has been elected to its board of directors. Caponi will join eight existing directors, including co-Chairmen Eric Allyn and Peer Allyn Soderberg M.D.; Welch Allyn president and CEO, Steve Meyer; Tasha Allyn Given, Larry Buckelew, Barry Wilson, Greg Norden and Craig Reynolds.
“We’re very excited to have Vincent join our board of directors,” said Steve Meyer, president and CEO at Welch Allyn. “He has an extensive experience in healthcare administration which will be a great benefit to Welch Allyn during these times of rapid change in our industry”.
Caponi, currently the Executive Chairman of the Board at St. Vincent Health and a Senior Vice President at Ascension, has more than 38 years’ experience in the healthcare industry. Formerly CEO of St. Vincent Health and Ascension Health Ministry Market Leader for Indiana, Caponi developed the St. Vincent Health ministry to a 22-hospital system, and one of Indiana’s largest employers. He oversaw the integration of eight critical access hospitals; multiple joint ventures; hospital expansions; and affiliations with health providers and community partners.
Prior to joining St. Vincent Health, he served as President and Chief Executive Officer at St. Vincent’s Hospital in Birmingham, AL. Earlier in his career, Caponi was president and chief executive officer of St. Joseph Hospital in Augusta, GA, and the administrator of United Memorial Hospital in Greenville, MI.
“I am extremely excited about joining Welch Allyn’s Board of Directors. Welch Allyn has been a preeminent brand in healthcare for almost 100 years and I look forward to contributing to their success in any way I can,” said Caponi.
Caponi holds a master’s degree in Healthcare Administration from Central Michigan University and a Bachelor of Arts from Xavier University. He serves on boards for Xavier University, Choice Trust, and Little Sisters of the Poor, Indiana Health Information Exchange, Indiana Hospital Association, Indianapolis Symphony Orchestra and the Indiana Chamber of Commerce. Caponi is past board member for the Boy Scouts of America, and former chairman of Brebeuf Jesuit Preparatory School and the United Way of Central Indiana. In addition, he is actively involved with the Archdiocese of Indianapolis.